Literature DB >> 1424190

Peripheral bone density in women with untreated multinodular goitre.

A H Mudde1, F J Reijnders, A C Kruseman.   

Abstract

OBJECTIVES: We wished to determine whether women with multinodular goitre and spontaneous subclinical hyperthyroidism have decreased bone density. DESIGN AND
SUBJECTS: Bone density was measured at the distal and proximal forearm. Data were expressed as Z-scores relative to the mean values out of 125 control subjects matched for age and menopause. The Z-scores of 23 women with subclinical hyperthyroid goitre (TSH < 0.1 mU/l and normal values for FT4 and total T3) and of 54 women with euthyroid goitre were compared. MEASUREMENTS: Bone density was measured by single photon absorptiometry. TSH was measured by IRMA, FT4 by RIA.
RESULTS: Relative to the euthyroid goitre subjects the mean +/- SEM Z-scores of both the distal and proximal forearm density were lower (-0.69 +/- 0.17 vs -0.1 +/- 0.18, P < 0.05 and -0.5 +/- 0.18 vs 0.07 +/- 0.18, P < 0.05, respectively). Median (range) FT4 in the subclinical hyperthyroid goitre subjects was significantly higher than euthyroid goitre subjects (15.6 (11-23.2) pmol/l vs 11.9 (8.3-18.3) pmol/l, P < 0.001) although still within the normal range. FT4 correlated inversely with Z-scores of both distal and proximal forearm bone density in the subjects with subclinical hyperthyroidism (r = -0.42, P < 0.05 and r = -0.43, P < 0.05, respectively), but not in the euthyroid goitre subjects.
CONCLUSION: These findings indicate that women with untreated multinodular goitre and subclinical hyperthyroidism have reduced bone density in the forearm.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424190     DOI: 10.1111/j.1365-2265.1992.tb02280.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

1.  Endogenous subclinical hyperthyroidism may not lead to bone loss in premenopausal women.

Authors:  T Saler; S Ahbab; Z A Sağlam; Ş Ö Keşkek; S Kurnaz
Journal:  Hippokratia       Date:  2014 Jul-Sep       Impact factor: 0.471

2.  Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves' disease.

Authors:  T Majima; Y Komatsu; K Doi; C Takagi; M Shigemoto; A Fukao; T Morimoto; J Corners; K Nakao
Journal:  Osteoporos Int       Date:  2006-04-07       Impact factor: 4.507

Review 3.  Subclinical hyperthyroidism: to treat or not to treat?

Authors:  E H Hoogendoorn; M den Heijer; A P J van Dijk; A R Hermus
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

Review 4.  Subclinical thyroid disease.

Authors:  J W Elte; A H Mudde; A C Nieuwenhuijzen Kruseman
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

Review 5.  Bone disease in thyrotoxicosis.

Authors:  P Amaresh Reddy; C V Harinarayan; Alok Sachan; V Suresh; G Rajagopal
Journal:  Indian J Med Res       Date:  2012-03       Impact factor: 2.375

6.  Modeling the effect of levothyroxine therapy on bone mass density in postmenopausal women: a different approach leads to new inference.

Authors:  Babak Mohammadi; Vahid Haghpanah; Seyed Mohammad Tavangar; Bagher Larijani
Journal:  Theor Biol Med Model       Date:  2007-06-09       Impact factor: 2.432

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.